# Implementation of PrEP to HIV in Brazilian Transgender Women

> **NCT03220152** · PHASE4 · UNKNOWN · sponsor: **Oswaldo Cruz Foundation** · enrollment: 120 (estimated)

## Conditions studied

- HIV, Prevention

## Interventions

- **DRUG:** emtricitabine / tenofovir 200/300 mg

## Key facts

- **NCT ID:** NCT03220152
- **Lead sponsor:** Oswaldo Cruz Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-10
- **Primary completion:** 2019-07
- **Final completion:** 2020-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03220152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03220152, "Implementation of PrEP to HIV in Brazilian Transgender Women". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03220152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*